Giuseppina Farina, MD, PhD
Research Assistant Professor
Boston University School of Medicine
Dept of Medicine
Rheumatology

MD, University of Rome
PhD, University of Rome




I have a broad background in clinical and research activities, with specific training and expertise in key research areas for this application. As a postdoctoral fellow I have focused my attention on translational studies, bridging clinical problems in scleroderma with molecular pathogenesis of skin, pulmonary hypertension and pulmonary fibrosis

Member
Boston University
Arthritis & Autoimmune Diseases Research Center




The Role of EBV in Monocyte Activation in Scleroderma Vasculopathy and Fibrosis
04/01/2018 - 09/30/2020 (PI)
Scleroderma Foundation


Neuroimmune Molecules in Scleroderma lung fibrosis
04/01/2016 - 03/31/2020 (Subcontract PI)
Yale University NIH NHLBI
5R01HL125850-04

Innate Immune Modulation in Scleroderma Fibroblasts by EBV Infection
01/15/2014 - 07/15/2016 (PI)
Scleroderma Foundation


Interplay between Type I IFN and TGF-beta signaling in systematic sclerosis
04/01/2012 - 03/31/2015 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5R03AR062721-03



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Farina A, Rosato E, York M, Gewurz BE, Trojanowska M, Farina GA. Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma. Front Immunol. 2021; 12:651013.View Related Profiles. PMID: 33953718; PMCID: PMC8089375; DOI: 10.3389/fimmu.2021.651013;
     
  2. Ryu C, Walia A, Ortiz V, Perry C, Woo S, Reeves BC, Sun H, Winkler J, Kanyo JE, Wang W, Vukmirovic M, Ristic N, Stratton EA, Meena SR, Minasyan M, Kurbanov D, Liu X, Lam TT, Farina G, Gomez JL, Gulati M, Herzog EL. Bioactive Plasma Mitochondrial DNA Is Associated With Disease Progression in Scleroderma-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2020 11; 72(11):1905-1915. PMID: 32602227; PMCID: PMC8081728; DOI: 10.1002/art.41418;
     
  3. Gonnella R, Dimarco M, Farina GA, Santarelli R, Valia S, Faggioni A, Angeloni A, Cirone M, Farina A. BFRF1 protein is involved in EBV-mediated autophagy manipulation. Microbes Infect. 2020 Nov - Dec; 22(10):585-591. PMID: 32882412
     
  4. Dreyfus DH, Farina A, Farina GA. Correction to: Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease. Immunol Res. 2019 Oct; 67(4-5):460. PMID: 31773489
     
  5. Dreyfus DH, Farina A, Farina GA. Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease. Immunol Res. 2018 12; 66(6):686-695. PMID: 30552620
     
  6. Farina A, Peruzzi G, Lacconi V, Lenna S, Quarta S, Rosato E, Vestri AR, York M, Dreyfus DH, Faggioni A, Morrone S, Trojanowska M, Farina GA. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res Ther. 2017 Feb 28; 19(1):39.View Related Profiles. PMID: 28245863; PMCID: PMC5331713; DOI: 10.1186/s13075-017-1237-9;
     
  7. Yadav S, Libotte F, Buono E, Valia S, Farina GA, Faggioni A, Farina A. EBV early lytic protein BFRF1 alters emerin distribution and post-translational modification. Virus Res. 2017 03 15; 232:113-122. PMID: 28238874
     
  8. Farina A, Farina GA. Fresh Insights into Disease Etiology and the Role of Microbial Pathogens. Curr Rheumatol Rep. 2016 Jan; 18(1):1. PMID: 26700911; DOI: 10.1007/s11926-015-0552-x;
     
  9. Lenna S, Assassi S, Farina GA, Mantero JC, Scorza R, Lafyatis R, Farber HW, Trojanowska M. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients. Arthritis Res Ther. 2015; 17:363.View Related Profiles. PMID: 26669670; PMCID: PMC4704539; DOI: 10.1186/s13075-015-0881-1;
     
  10. Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J Clin Invest. 2015 Jul 1; 125(7):2795-807.View Related Profiles. PMID: 26098215; PMCID: PMC4563675; DOI: 10.1172/JCI77958;
     
Showing 10 of 30 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 30 publications over 17 distinct years, with a maximum of 5 publications in 2010 and 2013

YearPublications
19991
20011
20022
20061
20081
20091
20105
20111
20122
20135
20152
20161
20172
20181
20191
20202
20211

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

innate immunity

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:

75 E. Newton St Evans Building
Boston MA 02118
Google Map


Farina's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department